Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 10,734 | 6,161 | 143 | 1,031 | 361 |
| Cost of Goods | 200 | N/A | N/A | N/A | N/A |
| Gross Profit | 10,534 | 5,085 | 143 | 1,031 | 361 |
| Operating Expenses | 151,112 | 139,827 | 142,729 | 130,143 | 111,766 |
| Operating Income | -140,378 | -133,666 | -142,586 | -129,112 | -111,405 |
| Other Income | 12,533 | 11,031 | 12,495 | 13,475 | 14,631 |
| Pre-tax Income | -127,845 | -122,635 | -130,091 | -115,637 | -96,774 |
| Net Income Continuous | -127,845 | -122,815 | -130,091 | -115,637 | -96,774 |
| Net Income | $-127,845 | $-122,815 | $-130,091 | $-115,637 | $-96,774 |
| EPS Basic Total Ops | -1.23 | -1.30 | -1.38 | -1.23 | -1.04 |
| EPS Basic Continuous Ops | -1.23 | -1.29 | -1.38 | -1.23 | -1.04 |
| EPS Diluted Total Ops | -1.23 | -1.30 | -1.38 | -1.23 | -1.04 |
| EPS Diluted Continuous Ops | -1.23 | -1.29 | -1.38 | -1.23 | -1.04 |
| EPS Diluted Before Non-Recurring Items | -1.23 | -1.29 | -1.38 | -1.23 | -1.04 |
| EBITDA(a) | $-141,438 | $-135,406 | $-145,175 | $-132,867 | $-114,856 |